Treatment of Hyrocephaly

Evaluation of the Success rate of Endoscopic third Ventriculostomy for Treatment of Hyrocephaly Caused by Vestibular Shwaannoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201108027198N1

Enrollment

Registered

2012-02-04

Start date

2012-01-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrocephalus. Obstructive hydrocephalus

Interventions

Endoscopic third Ventriculostomy.

Treatment - Surgery

Endoscopic third Ventriculostomy

Eligibility

Sex/Gender

All

Age

1 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criterias:Patients aged 6 months or more;Hydrocephaly confirmed by brain CT scan or MRI findings ;Vestibular Schwannoma seen on MRI or CT scan; Positive signs of Increased Intracranial Pressure; acceptance of informed consent.Exclusion criterias:negative history of meningitis; abscence of intraventricular or subarachnoid hemorrhage in patients history.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of Hydrocephaly. Timepoint: 2weeks.2 ms.6 ms.1 year. Method of measurement: MRI.	—

Secondary

Measure	Time frame
Rsponse to Treatment. Timepoint: 2 weeks,2 months,6 months,1 year. Method of measurement: Clinical Examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Alireza Khoshnevisan

Medical Department of Tehran University

info@shariatihospital.com+98 21 8822 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026